JP Patent

JP2024541978A — 進行期パーキンソン病のためのホスレボドパ／ホスカルビドパ皮下投与治療

Assigned to AbbVie Inc · Expires 2024-11-13 · 2y expired

What this patent protects

本開示は、進行期パーキンソン病のための安全かつ有効な皮下投与治療に関する。

USPTO Abstract

本開示は、進行期パーキンソン病のための安全かつ有効な皮下投与治療に関する。

Drugs covered by this patent

Patent Metadata

Patent number
JP2024541978A
Jurisdiction
JP
Classification
—
Expires
2024-11-13
Drug substance claim
No
Drug product claim
No
Assignee
AbbVie Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.